|
Volumn 513, Issue 7516, 2014, Pages 105-109
|
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
a a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
B RAF KINASE;
BRAF PROTEIN, HUMAN;
INDOLE DERIVATIVE;
INITIATION FACTOR 4A;
INITIATION FACTOR 4E;
INITIATION FACTOR 4F;
INITIATION FACTOR 4G;
MITOGEN ACTIVATED PROTEIN KINASE KINASE;
PROTEIN KINASE INHIBITOR;
SILVESTROL;
SULFONAMIDE;
TRITERPENE;
VEMURAFENIB;
ANIMAL;
ARTICLE;
CELL DEATH;
CHEMISTRY;
COLON TUMOR;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG POTENTIATION;
DRUG RESISTANCE;
DRUG SCREENING;
FEMALE;
GENETICS;
HUMAN;
MELANOMA;
METABOLISM;
MOUSE;
PATHOLOGY;
PHOSPHORYLATION;
PROTEIN BINDING;
SIGNAL TRANSDUCTION;
THYROID TUMOR;
TUMOR CELL LINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL DEATH;
CELL LINE, TUMOR;
COLONIC NEOPLASMS;
DRUG RESISTANCE, NEOPLASM;
DRUG SYNERGISM;
EUKARYOTIC INITIATION FACTOR-4A;
EUKARYOTIC INITIATION FACTOR-4E;
EUKARYOTIC INITIATION FACTOR-4F;
EUKARYOTIC INITIATION FACTOR-4G;
FEMALE;
HUMANS;
INDOLES;
MAP KINASE SIGNALING SYSTEM;
MELANOMA;
MICE;
MITOGEN-ACTIVATED PROTEIN KINASE KINASES;
PHOSPHORYLATION;
PROTEIN BINDING;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS B-RAF;
SIGNAL TRANSDUCTION;
SULFONAMIDES;
THYROID NEOPLASMS;
TRITERPENES;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 84907216956
PISSN: None
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/nature13572 Document Type: Article |
Times cited : (285)
|
References (0)
|